Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Herein, we review the epitope approach to vaccine development, and discuss how knowledge of HLA supertypes might be used as a tool in the development of such vaccines. After reviewing the main structural features of the A2-, A3-, B7-, and B44- supertype alleles, and biological data demonstrating their immunological relevance, we analyze the frequency at which these supertype alleles are expressed in various ethnicities and discuss the relevance of those observations to vaccine development. Next, the existence of five new supertypes (A1, A24, B27, B58, and B62) is reported. As a result, it is possible to account for the predominance of all known HLA class I with only nine main functional binding specificities. The practical implications of this finding, as well as its relevance to understanding the functional implication of MHC polymorphism in humans, are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individual HLA-I alleles are classified into 12 discrete supertypes (52, 53), on the basis of similar peptide-anchor–binding specificities (26, 52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [52]
In the citing paper
“These supertypes together cover most HLA-A and HLA-B alleles found in distinct populations (52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [52]
Citations
Cites
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411 · cited 5×
“Independent observations demonstrate that the motif of the mouse class I allele L is identical to the B7-supermotif (Corr et al. 1992; Falk et al. 1991) While the necessary task of fully exploring and cataloging MHC polymorphism continues, we have begun to appreciate the common denominators and similarities hidden wit…”
BackgroundInfluentialRosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183 · cited 4×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundInfluentialGoulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgana, B., Edwards, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-212 · Cited by 1,116 · cited 1×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundRefined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution
Saper, M. A., Bjorkman, P. J., & Wiley, D. C. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90567-p · Cited by 1,077 · cited 2×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains (Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundMethodThe Biochemistry and Cell Biology of Antigen Processing and Presentation
Germain, R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.403 · Cited by 1,020 · cited 1×
“The complex of a major histocompatibilty complex (MHC) molecule and a peptidic antigen acts as the ligand recognized by MHC-restricted T cells (Garcia et al. 1999; Germain and Margulies 1993; Yewdell and Bennink 1999).”
BackgroundCrystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2K b
Fremont, D. H., Matsumura, M., Stura, E. A., Peterson, P. A., & Wilson, L. A. (1992) · Science · doi:10.1126/science.1323877 · Cited by 861 · cited 1×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains ( Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundSette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5586 · Cited by 830 · cited 1×
“…peptide-MHC binding have also been established (Engelhard 1994; Joyce and Natheson 1994; Sette and Grey 1992; Sidney et al. 1998), and the threshold of affinity associated with generation of immune responses has also been elucidated (Schaeffer et al. 1989; Sette et al. 1994; Southwood et al. 1998).”
BackgroundSelf-citationIdentification of self peptides bound to purified HLA-B27
Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R., & Wiley, D. C. (1991) · Nature · doi:10.1038/353326a0 · Cited by 827 · cited 5×
“Pool sequencing motifs for peptides bound to HLAB*1401-02, B*1503, B*1509, B*1510, B*1518, B*380102, B*3901, B*3902, B*3903-04, B*4801-02, B*7301, and B*2701-08 (Barber et al. 1996a, 1997; Boisgérault et al. 1996; DiBrino et al. 1994b; Falk et al. 1995c; Rötzschke et al. 1994; Garcia et al. 1997; Jardetzky et al. 1991…”
BackgroundInfluential
Cited by
Items 601–636 of 636
Novel Immunogens Of Cellular Immunity Revealed Using In Vitro Human Cell-based Approach
Schanen, B. C. (2012) · Journal of International Crisis and Risk Communication Research
Abidin, R. S. (2016) · The University of Queensland · doi:10.14264/uql.2017.36 · Cited by 4
Nagarajan, D. (2018) · Nottingham Trent University's Institutional Repository (Nottingham Trent Repository) · Cited by 1
Applications of Cutting-Edge Immunoproteomics Technology in Human Immunotherapy
Comber, J. D., & Philip, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-33946-3_2 · Cited by 1
Sant, A. J. (2003) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1015306.196306
Münz, C., & Chijioke, O. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735084294.793557461
Non metastasis protein 2 (NME2) is a potential target for leukemia-specific immunotherapyPreprint
Däbritz, T., Tschiedel, S., Cross, M. A., & Niederwieser, D. W. (2022) · Research Square · doi:10.21203/rs.3.rs-1855482/v1
Telomerase Reverse Transcriptase in Humans: From Biology to Cancer Immunity
Dosset, M., Castro, A., Su, X., Carter, H. K., & Zanetti, M. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_49
Dynamics of Ankylosing Spondylitis-associated Arthritogenic Peptide-MHC I interactionsPreprint
Kıvrak, S., Dilek, Y. E., Kara, İ., Özkaya, Ş. Ç., Abacar, K., Erzık, C., Atagündüz, P., & Akçapınar, G. B. (2023) · Research Square · doi:10.21203/rs.3.rs-3474723/v1
Chen, S., & Zhang, H. (2024) · Immunology · doi:10.1111/imm.13753
“The vaccines are focused on HLA-A 2.01 and HLA-B 7.02 MHCIa supertypes that are prevalent among approximately 48% of the human population [12].”
BackgroundInfluentialAdditional file 2 of HLA-Clus: HLA class I clustering based on 3D structure
Shen, Y., Parks, J. M., & Smith, J. C. (2023) · Figshare · doi:10.6084/m9.figshare.22792691
In silico functional analysis of the human, chimpanzee, and gorilla MHC-A repertoires
Dodd, G. K., & Keşmir, C. (2025) · Immunogenetics · doi:10.1007/s00251-024-01369-1 · Cited by 1
“Despite the highly polymorphic nature of HLA genes, these molecules can be classified into a few supertypes based on their peptide binding specificities (Sette & Sidney 1999; Sidney et al. 1996, 2008).”
Rana, D. R., Manandhar, S., Singh, A., Hagge, D. A., & Joshi, J. (2025) · medRxiv · doi:10.1101/2025.05.24.25326117
Ngandu, N. K., Fielding, B. C., Heusden, P. V., Mcinga, K., Francis, K., & Harkins, G. W. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013261 · Cited by 1
“HLA-peptide pairs with available binding affinity results (i.e., strong, weak or non-binders) were extracted; [3] Fig 1Bii: peptide positions predicted in at least two infection waves alignments (to estimate dominant immune responses) were analyzed further; [4] hypotheses of predicted immune escape…”
Валерьевич, С. Т., Kopat, V. V., Даниленко, Е. Д., Churin, A. A., Milichkina, A. M., Ramsay, E. S., Dukhovlinov, I. V., Simbirtsev, A. S., & Тотолян, А. А. (2025) · Viruses · doi:10.3390/v17091186
SARS-CoV-2 infection dynamics in a MHCI-mismatched lung transplant recipient
Fuchs, J., Karl, V., Hettich, I., Alvarado, J., Eckert, D., Jaki, L., Kohl, A.-K., Kremser, A., Maks, A., Terschluse, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63681-y
“Therefore, further analyses with more patients, including different HLA-mismatch patterns (based on eplet and supertype classi fi cations) and non-polymorphic HLA-E 42,43 , may elucidate the protective bene fi t of the graft ’ s transplanted immune system.”
Resource: A compendium of HLA types and expression in pediatric cancer models
Guan, Y., Mahajan, I., Ajith, V., Sun, D., Woodhouse, I. B., Shamekhi, T., Faridi, P., Firestein, R., & Sun, C. X. (2025) · iScience · doi:10.1016/j.isci.2025.113887
Additional file 3 of Efficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine
Cen, L., Zhang, Z., Sun, Y., Wu, N., Shao, J., Qian, Z., Tian, M., Ke, Y., & Liu, B. (2024) · Figshare · doi:10.6084/m9.figshare.26743025
Additional file 4 of Efficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine
Cen, L., Zhang, Z., Sun, Y., Wu, N., Shao, J., Qian, Z., Tian, M., Ke, Y., & Liu, B. (2024) · Figshare · doi:10.6084/m9.figshare.26743028
Additional file 1 of Efficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine
Cen, L., Zhang, Z., Sun, Y., Wu, N., Shao, J., Qian, Z., Tian, M., Ke, Y., & Liu, B. (2024) · Figshare · doi:10.6084/m9.figshare.26170510
Additional file 2 of Efficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine
Cen, L., Zhang, Z., Sun, Y., Wu, N., Shao, J., Qian, Z., Tian, M., Ke, Y., & Liu, B. (2024) · Figshare · doi:10.6084/m9.figshare.26170692
Additional file 1 of HLA-Clus: HLA class I clustering based on 3D structure
Shen, Y., Parks, J. M., & Smith, J. C. (2023) · Figshare · doi:10.6084/m9.figshare.22792688
Soares, G. G., Sarcinelli, M. C. F., Damas, M. S. F., Crispim, N. R., Soares‐Costa, A., & Pranchevicius, M. C. D. S. (2026) · Future Microbiology · doi:10.1080/17460913.2026.2629192
Peptides multi-épitopiques d’intérêt vaccinal appliqués aux leishmanioses humaines
Hamrouni, S. (2019) · theses.fr (ABES) · doi:10.70675/31ecdc88z3c18z4e17zba09za3e246a04bf9
Fortuin, T. L., Nkone, P., Loubser, S. A., Tiemessen, C. T., & Mayaphi, S. H. (2026) · Immunology · doi:10.1111/imm.70156
Dorvash, M., Potriquet, J., Ryumin, P., Ayala, R., Le, N. H., Aranha, R., Illing, P. T., Croft, N. P., Ramarathinam, S. H., & Purcell, A. W. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c08123
Benyamini, P. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835523
“Several of these epitopes demonstrated cross-supertype binding (e.g., HLA-A 02, A 03, B*07 clusters), a property strongly associated with immunodominance and enhanced population-level coverage (119, 120, 123).”
A protocol for computational design of mRNA vaccines with high functionality and specificity
Ramadan, M. A., ElGohary, H. M., Faraag, A. H., & Mysara, M. (2026) · Biology Direct · doi:10.1186/s13062-026-00846-9
“Effective epitope selection should include both CD8 + and CD4 + T-cell epitopes, requiring compatibility with MHC class I and class II human leukocyte antigen (HLA) molecules to ensure a coordinated cellular immune response [37, 38].”
Masondo, N., Gordon, M. L., & Chiliza, T. E. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1724374
Non-canonical microproteins as targets for shared-antigen cancer immunotherapy
Fierro-Monti, I. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1984200
Metadata
- Authors
- Sette, A., & Sidney, J.
- ORCID
- Venue
- Immunogenetics
- Published
- 1999-11
- Volume
- 50
- Issue
- 3-4
- Pages
- 201-212
- ISSN
- 0093-7711 (ISSN-L)
- 1432-1211
- OpenAlex
- W2052321000
- Cited by
- 635
- References
- 115
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 19 · 2023: 18 · 2022: 16 · 2021: 21 · 2020: 25 · 2019: 14 · 2018: 20 · 2017: 19 · 2016: 14 · 2015: 26 · 2014: 26 · 2013: 27 · 2012: 37
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Immunogenetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01ai045241-010, n01ai095362-000)
- National Institute of Allergy and Infectious Diseases (N01 AI-45241, N01-AI-95362)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- HLA-A, HLA-B, MHC polymorphism
- MeSH terms
- Alleles, Amino Acid Sequence, Animals, Epitopes, Humans, Molecular Sequence Data, Polymorphism, Genetic, HLA-A Antigens, HLA-B Antigens, Histocompatibility Antigens Class I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.